ReP USP - Resultado da busca

Artigo de periodico
Plant bZIP Proteins: Potential use in Agriculture - A Review (2024)
Souza, Cláudia Regina Batista de ; Serrão, Cleyson Pantoja; Barros, Nicolle Louise Ferreira; Reis, Sávio Pinho dos; Marques, Deyvid Novaes
Source: Current Protein and Peptide Science. Unidade: ESALQ
Subjects: BIOTECNOLOGIA DE PLANTAS, DANOS POR FATORES AMBIENTAIS, EXPRESSÃO GÊNICA, FATORES DE TRANSCRIÇÃO, FITOPATÓGENOS, MELHORAMENTO GENÉTICO VEGETAL, PROTEÇÃO DE PLANTAS, PROTEÍNAS DE PLANTAS, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Cláudia Regina Batista de et al. Plant bZIP Proteins: Potential use in Agriculture - A Review. Current Protein and Peptide Science, v. 25, p. 107-119, 2024Tradução . . Disponível em: https://doi.org/10.2174/0113892037261763230925034348. Acesso em: 14 jun. 2024.
APA
Souza, C. R. B. de, Serrão, C. P., Barros, N. L. F., Reis, S. P. dos, & Marques, D. N. (2024). Plant bZIP Proteins: Potential use in Agriculture - A Review. Current Protein and Peptide Science, 25, 107-119. doi:10.2174/0113892037261763230925034348
NLM
Souza CRB de, Serrão CP, Barros NLF, Reis SP dos, Marques DN. Plant bZIP Proteins: Potential use in Agriculture - A Review [Internet]. Current Protein and Peptide Science. 2024 ; 25 107-119.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/0113892037261763230925034348
Vancouver
Souza CRB de, Serrão CP, Barros NLF, Reis SP dos, Marques DN. Plant bZIP Proteins: Potential use in Agriculture - A Review [Internet]. Current Protein and Peptide Science. 2024 ; 25 107-119.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/0113892037261763230925034348
Artigo de periodico
Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi (2024)
Prates, João Lucas Bruno; Lopes, Juliana Romano ; Chin, Chung Man ; Ferreira, Elizabeth Igne ; Santos, Jean Leandro dos ; Scarim, Cauê Benito
Source: Current Medicinal Chemistry. Unidade: FCF
Subjects: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS, DESENVOLVIMENTO DE PRODUTOS, PRODUTOS NOVOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRATES, João Lucas Bruno et al. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, v. 31, n. 16, p. 2285-2308, 2024Tradução . . Disponível em: https://dx.doi.org/10.2174/0109298673254864230921090. Acesso em: 14 jun. 2024.
APA
Prates, J. L. B., Lopes, J. R., Chin, C. M., Ferreira, E. I., Santos, J. L. dos, & Scarim, C. B. (2024). Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, 31( 16), 2285-2308. doi:10.2174/0109298673254864230921090
NLM
Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 jun. 14 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
Vancouver
Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 jun. 14 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
Editor de periodico
Current Topics in Medicinal Chemistry (2024)
Zhou, Jia (Editor); Andricopulo, Adriano Defini (Editor) ; Ferreira, Leonardo Luiz Gomes (Editor) ; Garcia, Célia Regina da Silva (Editor)
Unidades: IFSC, FCF
Assunto: QUÍMICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Current Topics in Medicinal Chemistry. . Sharjah: Bentham Science. . Acesso em: 14 jun. 2024. , 2024
APA
Current Topics in Medicinal Chemistry. (2024). Current Topics in Medicinal Chemistry. Sharjah: Bentham Science.
NLM
Current Topics in Medicinal Chemistry. 2024 ;[citado 2024 jun. 14 ]
Vancouver
Current Topics in Medicinal Chemistry. 2024 ;[citado 2024 jun. 14 ]
Artigo de periodico
Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells (2024)
Fernandes, Thais Batista ; Yang, Rosania; Ferreira, Glaucio Monteiro ; Souza, Priscila Oliveira de ; Lopes, Vitor Galvão ; Toledo, Mônica Franco Zannini Junqueira ; Roliano, Gabriela Gonçalves ; Debom, Gabriela Nogueira ; Vassiliades, Sandra Valeria ; Hassimotto, Neuza Mariko Aymoto ; Hirata, Mario Hiroyuki ; Braganhol, Elizandra ; Parise Filho, Roberto
Source: Letters in Drug Design & Discovery. Unidade: FCF
Subjects: GLIOMA, SISTEMA NERVOSO CENTRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Thais Batista et al. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells. Letters in Drug Design & Discovery, v. 21, p. 948-960, 2024Tradução . . Disponível em: https://doi.org/10.2174/1570180820666230131111033. Acesso em: 14 jun. 2024.
APA
Fernandes, T. B., Yang, R., Ferreira, G. M., Souza, P. O. de, Lopes, V. G., Toledo, M. F. Z. J., et al. (2024). Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells. Letters in Drug Design & Discovery, 21, 948-960. doi:10.2174/1570180820666230131111033
NLM
Fernandes TB, Yang R, Ferreira GM, Souza PO de, Lopes VG, Toledo MFZJ, Roliano GG, Debom GN, Vassiliades SV, Hassimotto NMA, Hirata MH, Braganhol E, Parise Filho R. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells [Internet]. Letters in Drug Design & Discovery. 2024 ; 21 948-960.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1570180820666230131111033
Vancouver
Fernandes TB, Yang R, Ferreira GM, Souza PO de, Lopes VG, Toledo MFZJ, Roliano GG, Debom GN, Vassiliades SV, Hassimotto NMA, Hirata MH, Braganhol E, Parise Filho R. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells [Internet]. Letters in Drug Design & Discovery. 2024 ; 21 948-960.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1570180820666230131111033
Artigo de periodico
Biomarkers in hypertension and hypertension-related disorders (2023)
Ribeiro, Patrícia de Carvalho ; Oliveira, Lucas Felipe; Mendes Filho, Daniel ; Parreira, Ricardo Cambraia; Vieira, Mariana Sousa; Marques, Bruno Lemes; Freitas, Elis Marra da Madeira; Silva, Walison N; Santiago, Helton da Costa ; Birbrair, Alexander ; Ulrich, Henning ; Silva, Valdo José Dias da; Resende, Rodrigo R
Source: Current Medicinal Chemistry. Unidade: IQ
Subjects: BIOMARCADORES, HIPERTENSÃO, DOENÇAS CARDIOVASCULARES, METABOLÔMICA, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Patrícia de Carvalho et al. Biomarkers in hypertension and hypertension-related disorders. Current Medicinal Chemistry, v. 30, n. 34, p. 3846-3879, 2023Tradução . . Disponível em: https://doi.org/10.2174/0929867329666220921113403. Acesso em: 14 jun. 2024.
APA
Ribeiro, P. de C., Oliveira, L. F., Mendes Filho, D., Parreira, R. C., Vieira, M. S., Marques, B. L., et al. (2023). Biomarkers in hypertension and hypertension-related disorders. Current Medicinal Chemistry, 30( 34), 3846-3879. doi:10.2174/0929867329666220921113403
NLM
Ribeiro P de C, Oliveira LF, Mendes Filho D, Parreira RC, Vieira MS, Marques BL, Freitas EM da M, Silva WN, Santiago H da C, Birbrair A, Ulrich H, Silva VJD da, Resende RR. Biomarkers in hypertension and hypertension-related disorders [Internet]. Current Medicinal Chemistry. 2023 ; 30( 34): 3846-3879.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/0929867329666220921113403
Vancouver
Ribeiro P de C, Oliveira LF, Mendes Filho D, Parreira RC, Vieira MS, Marques BL, Freitas EM da M, Silva WN, Santiago H da C, Birbrair A, Ulrich H, Silva VJD da, Resende RR. Biomarkers in hypertension and hypertension-related disorders [Internet]. Current Medicinal Chemistry. 2023 ; 30( 34): 3846-3879.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/0929867329666220921113403
Artigo de periodico
Effect of postharvest treatments on the biosynthesis of fruit volatile compounds: a literature review (2023)
Magalhães, Hilton César Rodrigues ; Garruti, Deborah S ; Gandra, Eliezer Avila ; Purgatto, Eduardo
Source: Current Nutrition and Food Science. Unidade: FCF
Subjects: HORMÔNIOS, ÁCIDOS GRAXOS, AMINOÁCIDOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAGALHÃES, Hilton César Rodrigues et al. Effect of postharvest treatments on the biosynthesis of fruit volatile compounds: a literature review. Current Nutrition and Food Science, v. 19, n. 3, p. 246-261, 2023Tradução . . Disponível em: https://doi.org/10.2174/1573401318666220527123341. Acesso em: 14 jun. 2024.
APA
Magalhães, H. C. R., Garruti, D. S., Gandra, E. A., & Purgatto, E. (2023). Effect of postharvest treatments on the biosynthesis of fruit volatile compounds: a literature review. Current Nutrition and Food Science, 19( 3), 246-261. doi:10.2174/1573401318666220527123341
NLM
Magalhães HCR, Garruti DS, Gandra EA, Purgatto E. Effect of postharvest treatments on the biosynthesis of fruit volatile compounds: a literature review [Internet]. Current Nutrition and Food Science. 2023 ; 19( 3): 246-261.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1573401318666220527123341
Vancouver
Magalhães HCR, Garruti DS, Gandra EA, Purgatto E. Effect of postharvest treatments on the biosynthesis of fruit volatile compounds: a literature review [Internet]. Current Nutrition and Food Science. 2023 ; 19( 3): 246-261.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1573401318666220527123341
Trabalho de evento-anais periodico
Nutritional patterns, anthropometric and sociodemographic aspects associated with gestational diabetes mellitus (2023)
Pinta, Paola Cristina Toapanta ; Morales, S. Vasco; Sartorelli, Daniela Saes ; Moisés, Elaine Christine Dantas
Source: ESPOCH Congresses: The Ecuadorian Journal of S.T.E.A.M.. Conference titles: Congreso internacional de ciencia tecnología emprendimiento e innovación sectei-espoch 2022. Unidade: FMRP
Subjects: DIABETES MELLITUS, GRAVIDEZ, SAÚDE MATERNO-INFANTIL, ESTADO NUTRICIONAL, ATIVIDADE FÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTA, Paola Cristina Toapanta et al. Nutritional patterns, anthropometric and sociodemographic aspects associated with gestational diabetes mellitus. ESPOCH Congresses: The Ecuadorian Journal of S.T.E.A.M. Dubai: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.18502/espoch.v3i1.14419. Acesso em: 14 jun. 2024. , 2023
APA
Pinta, P. C. T., Morales, S. V., Sartorelli, D. S., & Moisés, E. C. D. (2023). Nutritional patterns, anthropometric and sociodemographic aspects associated with gestational diabetes mellitus. ESPOCH Congresses: The Ecuadorian Journal of S.T.E.A.M.. Dubai: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.18502/espoch.v3i1.14419
NLM
Pinta PCT, Morales SV, Sartorelli DS, Moisés ECD. Nutritional patterns, anthropometric and sociodemographic aspects associated with gestational diabetes mellitus [Internet]. ESPOCH Congresses: The Ecuadorian Journal of S.T.E.A.M. 2023 ; 3( 1): 121-138.[citado 2024 jun. 14 ] Available from: https://doi.org/10.18502/espoch.v3i1.14419
Vancouver
Pinta PCT, Morales SV, Sartorelli DS, Moisés ECD. Nutritional patterns, anthropometric and sociodemographic aspects associated with gestational diabetes mellitus [Internet]. ESPOCH Congresses: The Ecuadorian Journal of S.T.E.A.M. 2023 ; 3( 1): 121-138.[citado 2024 jun. 14 ] Available from: https://doi.org/10.18502/espoch.v3i1.14419
Artigo de periodico
Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents (2023)
Vassiliades, Sandra Valeria ; Borges, Lara Gimenez; Giarolla, Jeanine ; Parise Filho, Roberto
Source: Mini-Reviews in Medicinal Chemistry. Unidade: FCF
Subjects: HOMEOSTASE, TUBERCULOSE, ÁCIDO FÓLICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VASSILIADES, Sandra Valeria et al. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents. Mini-Reviews in Medicinal Chemistry, v. 23, n. 17, p. 1711-1732, 2023Tradução . . Disponível em: https://doi.org/10.2174/1389557523666230206163154. Acesso em: 14 jun. 2024.
APA
Vassiliades, S. V., Borges, L. G., Giarolla, J., & Parise Filho, R. (2023). Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents. Mini-Reviews in Medicinal Chemistry, 23( 17), 1711-1732. doi:10.2174/1389557523666230206163154
NLM
Vassiliades SV, Borges LG, Giarolla J, Parise Filho R. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents [Internet]. Mini-Reviews in Medicinal Chemistry. 2023 ; 23( 17): 1711-1732.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1389557523666230206163154
Vancouver
Vassiliades SV, Borges LG, Giarolla J, Parise Filho R. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents [Internet]. Mini-Reviews in Medicinal Chemistry. 2023 ; 23( 17): 1711-1732.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1389557523666230206163154
Artigo de periodico
Predicting dementia Due to alzheimer's disease and behavioral variant frontotemporal dementia using algorithms with the addenbrooke's cognitive examination-revised subscores combined with sociodemographic factors (2023)
Carvalho, Viviane Amaral ; Silva, Thaís Bento Lima da ; Mariano, Luciano Inácio ; Souza, Leonardo Cruz de ; Guimarães, Henrique Cerqueira; Bahia, Valéria Santoro; Nitrini, Ricardo ; Barbosa, Maira Tonidandel ; Yassuda, Monica Sanches ; Caramelli, Paulo
Source: Current Alzheimer Research. Unidades: EACH, FM
Assunto: DEMÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Viviane Amaral et al. Predicting dementia Due to alzheimer's disease and behavioral variant frontotemporal dementia using algorithms with the addenbrooke's cognitive examination-revised subscores combined with sociodemographic factors. Current Alzheimer Research, p. 01-09, 2023Tradução . . Disponível em: https://doi.org/10.2174/1567205020666230816160700. Acesso em: 14 jun. 2024.
APA
Carvalho, V. A., Silva, T. B. L. da, Mariano, L. I., Souza, L. C. de, Guimarães, H. C., Bahia, V. S., et al. (2023). Predicting dementia Due to alzheimer's disease and behavioral variant frontotemporal dementia using algorithms with the addenbrooke's cognitive examination-revised subscores combined with sociodemographic factors. Current Alzheimer Research, 01-09. doi:10.2174/1567205020666230816160700
NLM
Carvalho VA, Silva TBL da, Mariano LI, Souza LC de, Guimarães HC, Bahia VS, Nitrini R, Barbosa MT, Yassuda MS, Caramelli P. Predicting dementia Due to alzheimer's disease and behavioral variant frontotemporal dementia using algorithms with the addenbrooke's cognitive examination-revised subscores combined with sociodemographic factors [Internet]. Current Alzheimer Research. 2023 ; 01-09.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1567205020666230816160700
Vancouver
Carvalho VA, Silva TBL da, Mariano LI, Souza LC de, Guimarães HC, Bahia VS, Nitrini R, Barbosa MT, Yassuda MS, Caramelli P. Predicting dementia Due to alzheimer's disease and behavioral variant frontotemporal dementia using algorithms with the addenbrooke's cognitive examination-revised subscores combined with sociodemographic factors [Internet]. Current Alzheimer Research. 2023 ; 01-09.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1567205020666230816160700
Artigo de periodico
The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study (2023)
Serafim, Mateus Sá Magalhães ; Pantaleão, Simone Queiroz ; Silva, Elany Barbosa da ; McKerrow, James H. ; O’Donoghue, Anthony J. ; Mota, Bruno Eduardo Fernandes; Honorio, Kathia Maria ; Maltarollo, Vinícius Gonçalves
Source: Frontiers in Drug Discovery. Unidade: EACH
Assunto: INIBIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SERAFIM, Mateus Sá Magalhães et al. The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study. Frontiers in Drug Discovery, v. 3, p. 01-18, 2023Tradução . . Disponível em: https://doi.org/10.3389/fddsv.2023.1237655. Acesso em: 14 jun. 2024.
APA
Serafim, M. S. M., Pantaleão, S. Q., Silva, E. B. da, McKerrow, J. H., O’Donoghue, A. J., Mota, B. E. F., et al. (2023). The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study. Frontiers in Drug Discovery, 3, 01-18. doi:10.3389/fddsv.2023.1237655
NLM
Serafim MSM, Pantaleão SQ, Silva EB da, McKerrow JH, O’Donoghue AJ, Mota BEF, Honorio KM, Maltarollo VG. The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study [Internet]. Frontiers in Drug Discovery. 2023 ; 3 01-18.[citado 2024 jun. 14 ] Available from: https://doi.org/10.3389/fddsv.2023.1237655
Vancouver
Serafim MSM, Pantaleão SQ, Silva EB da, McKerrow JH, O’Donoghue AJ, Mota BEF, Honorio KM, Maltarollo VG. The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study [Internet]. Frontiers in Drug Discovery. 2023 ; 3 01-18.[citado 2024 jun. 14 ] Available from: https://doi.org/10.3389/fddsv.2023.1237655
Artigo de periodico
Otago exercise program plus cognitive dual-task can reduce fall risk, improve cognition and Functioning in Older Adults (2023)
Santos, Paula Clara; Machado, Dalmo Roberto Lopes ; Abdalla, Pedro Pugliesi ; Santos, Claúdia Vanessa; Lopes, Sofia; Martins, Anabela Correia; Mota, Jorge; Mesquita, Cristina
Source: Current Aging Science. Unidade: EEFERP
Subjects: EXERCÍCIO FÍSICO, COGNIÇÃO, IDOSOS, ATIVIDADE FÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Paula Clara et al. Otago exercise program plus cognitive dual-task can reduce fall risk, improve cognition and Functioning in Older Adults. Current Aging Science, v. 16, n. 1, p. 65-74, 2023Tradução . . Disponível em: https://doi.org/10.2174/1874609815666220827143753. Acesso em: 14 jun. 2024.
APA
Santos, P. C., Machado, D. R. L., Abdalla, P. P., Santos, C. V., Lopes, S., Martins, A. C., et al. (2023). Otago exercise program plus cognitive dual-task can reduce fall risk, improve cognition and Functioning in Older Adults. Current Aging Science, 16( 1), 65-74. doi:10.2174/1874609815666220827143753
NLM
Santos PC, Machado DRL, Abdalla PP, Santos CV, Lopes S, Martins AC, Mota J, Mesquita C. Otago exercise program plus cognitive dual-task can reduce fall risk, improve cognition and Functioning in Older Adults [Internet]. Current Aging Science. 2023 ; 16( 1): 65-74.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1874609815666220827143753
Vancouver
Santos PC, Machado DRL, Abdalla PP, Santos CV, Lopes S, Martins AC, Mota J, Mesquita C. Otago exercise program plus cognitive dual-task can reduce fall risk, improve cognition and Functioning in Older Adults [Internet]. Current Aging Science. 2023 ; 16( 1): 65-74.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1874609815666220827143753
Artigo de periodico
2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations (2023)
Cuppoloni, Andréa; Silva, João Vitor da ; Snape, Timothy James ; Lal, Samridhi ; Giarolla, Jeanine
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: MEDICAMENTO, METABOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUPPOLONI, Andréa et al. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations. Current Topics in Medicinal Chemistry, v. 23, n. 12, p. 1081-1089, 2023Tradução . . Disponível em: https://doi.org/10.2174/1568026623666230207120752. Acesso em: 14 jun. 2024.
APA
Cuppoloni, A., Silva, J. V. da, Snape, T. J., Lal, S., & Giarolla, J. (2023). 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations. Current Topics in Medicinal Chemistry, 23( 12), 1081-1089. doi:10.2174/1568026623666230207120752
NLM
Cuppoloni A, Silva JV da, Snape TJ, Lal S, Giarolla J. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 12): 1081-1089.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1568026623666230207120752
Vancouver
Cuppoloni A, Silva JV da, Snape TJ, Lal S, Giarolla J. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 12): 1081-1089.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1568026623666230207120752
Artigo de periodico
DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease (2023)
Souza, Márcia Maria de; Cenci, Arthur Ribeiro; Teixeira, Kerolain Faoro; Machado, Valkiria; Mendes, Majory Christina Garcia; Gonçalves, Ana Elisa; Dalmagro, Ana Paula; Cazarin, Camila André; Ferreira, Leonardo Luiz Gomes ; Oliveira, Aldo Sena de ; Andricopulo, Adriano Defini
Source: Current Medicinal Chemistry. Unidade: IFSC
Subjects: DOENÇA DE ALZHEIMER, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Márcia Maria de et al. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, v. 30, n. 6, p. 669-688, 2023Tradução . . Disponível em: https://doi.org/10.2174/0929867329666220620162018. Acesso em: 14 jun. 2024.
APA
Souza, M. M. de, Cenci, A. R., Teixeira, K. F., Machado, V., Mendes, M. C. G., Gonçalves, A. E., et al. (2023). DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, 30( 6), 669-688. doi:10.2174/0929867329666220620162018
NLM
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/0929867329666220620162018
Vancouver
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/0929867329666220620162018
Artigo de periodico
The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021 (2023)
Barbosa, Henrique; Thevenard, Fernanda; Reimão, Juliana Quero; Tempone, Andre Gustavo Tempone; Honorio, Kathia Maria ; Lago, Joao Henrique Ghilardi
Source: Current Topics in Medicinal Chemistry. Unidade: EACH
Assunto: DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Henrique et al. The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021. Current Topics in Medicinal Chemistry, v. 23, n. Ja 2023, p. 159-213, 2023Tradução . . Disponível em: https://doi.org/10.2174/1568026623666221212111514. Acesso em: 14 jun. 2024.
APA
Barbosa, H., Thevenard, F., Reimão, J. Q., Tempone, A. G. T., Honorio, K. M., & Lago, J. H. G. (2023). The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021. Current Topics in Medicinal Chemistry, 23( Ja 2023), 159-213. doi:10.2174/1568026623666221212111514
NLM
Barbosa H, Thevenard F, Reimão JQ, Tempone AGT, Honorio KM, Lago JHG. The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021 [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( Ja 2023): 159-213.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1568026623666221212111514
Vancouver
Barbosa H, Thevenard F, Reimão JQ, Tempone AGT, Honorio KM, Lago JHG. The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021 [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( Ja 2023): 159-213.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1568026623666221212111514
Artigo de periodico
Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles (2023)
Awasthi, Rajendra ; Singh, Anurag Kumar ; Mishra, Gaurav ; Maurya, Anand ; Dhiman, Neerupma ; Kharkwal, Harsha ; Sharma, Bhupesh ; Jha, Niraj Kumar ; Dua, Kamal ; Pinto, Terezinha de Jesus Andreoli ; Kulkarni, Giriraj T
Source: Letters in Drug Design & Discovery. Unidade: FCF
Subjects: NEOPLASIAS PULMONARES, NANOTECNOLOGIA, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AWASTHI, Rajendra et al. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles. Letters in Drug Design & Discovery, v. 20, n. 5, p. 499-516, 2023Tradução . . Disponível em: https://doi.org/10.2174/1570180819666220510133408. Acesso em: 14 jun. 2024.
APA
Awasthi, R., Singh, A. K., Mishra, G., Maurya, A., Dhiman, N., Kharkwal, H., et al. (2023). Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles. Letters in Drug Design & Discovery, 20( 5), 499-516. doi:10.2174/1570180819666220510133408
NLM
Awasthi R, Singh AK, Mishra G, Maurya A, Dhiman N, Kharkwal H, Sharma B, Jha NK, Dua K, Pinto T de JA, Kulkarni GT. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles [Internet]. Letters in Drug Design & Discovery. 2023 ; 20( 5): 499-516.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1570180819666220510133408
Vancouver
Awasthi R, Singh AK, Mishra G, Maurya A, Dhiman N, Kharkwal H, Sharma B, Jha NK, Dua K, Pinto T de JA, Kulkarni GT. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles [Internet]. Letters in Drug Design & Discovery. 2023 ; 20( 5): 499-516.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1570180819666220510133408
Artigo de periodico
Hexokinase and glycolysis: between brain cells life and death (2023)
Mata, Larissa Rodrigues Souza da ; Santos, Laís Damásio dos ; César, Marcelo de Cerqueira
Source: Current Chemical Biology. Unidade: FZEA
Subjects: DOENÇA DE ALZHEIMER, NEURÔNIOS, BIOQUÍMICA, NEUROCIÊNCIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATA, Larissa Rodrigues Souza da e SANTOS, Laís Damásio dos e CÉSAR, Marcelo de Cerqueira. Hexokinase and glycolysis: between brain cells life and death. Current Chemical Biology, v. 17, n. 2, p. 91-123, 2023Tradução . . Disponível em: https://doi.org/10.2174/2212796817666230510095530. Acesso em: 14 jun. 2024.
APA
Mata, L. R. S. da, Santos, L. D. dos, & César, M. de C. (2023). Hexokinase and glycolysis: between brain cells life and death. Current Chemical Biology, 17( 2), 91-123. doi:10.2174/2212796817666230510095530
NLM
Mata LRS da, Santos LD dos, César M de C. Hexokinase and glycolysis: between brain cells life and death [Internet]. Current Chemical Biology. 2023 ; 17( 2): 91-123.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/2212796817666230510095530
Vancouver
Mata LRS da, Santos LD dos, César M de C. Hexokinase and glycolysis: between brain cells life and death [Internet]. Current Chemical Biology. 2023 ; 17( 2): 91-123.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/2212796817666230510095530
Editor de periodico
Current Topics in Medicinal Chemistry (2023)
Zhou, Jia (Editor); Andricopulo, Adriano Defini (Editor) ; Ferreira, Leonardo Luiz Gomes (Editor) ; Garcia, Célia Regina da Silva (Editor)
Unidades: IFSC, FCF
Assunto: QUÍMICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Current Topics in Medicinal Chemistry. . Sharjah: Bentham Science. . Acesso em: 14 jun. 2024. , 2023
APA
Current Topics in Medicinal Chemistry. (2023). Current Topics in Medicinal Chemistry. Sharjah: Bentham Science.
NLM
Current Topics in Medicinal Chemistry. 2023 ;[citado 2024 jun. 14 ]
Vancouver
Current Topics in Medicinal Chemistry. 2023 ;[citado 2024 jun. 14 ]
Artigo de periodico
Cruzain inhibitors: state-of-art of novel synthetic strategies (2023)
Morais, Pedro Alves Bezerra ; Trossini, Gustavo Henrique Goulart
Source: Current Organic Chemistry. Unidade: FCF
Subjects: DOENÇA DE CHAGAS, SÍNTESE ORGÂNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS, Pedro Alves Bezerra e TROSSINI, Gustavo Henrique Goulart. Cruzain inhibitors: state-of-art of novel synthetic strategies. Current Organic Chemistry, v. 27, n. 4, p. 243-247, 2023Tradução . . Disponível em: https://doi.org/10.2174/1385272827666230418100932. Acesso em: 14 jun. 2024.
APA
Morais, P. A. B., & Trossini, G. H. G. (2023). Cruzain inhibitors: state-of-art of novel synthetic strategies. Current Organic Chemistry, 27( 4), 243-247. doi:10.2174/1385272827666230418100932
NLM
Morais PAB, Trossini GHG. Cruzain inhibitors: state-of-art of novel synthetic strategies [Internet]. Current Organic Chemistry. 2023 ; 27( 4): 243-247.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1385272827666230418100932
Vancouver
Morais PAB, Trossini GHG. Cruzain inhibitors: state-of-art of novel synthetic strategies [Internet]. Current Organic Chemistry. 2023 ; 27( 4): 243-247.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1385272827666230418100932
Artigo de periodico-carta/editorial
Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach (2023)
Santos, Rafael Guimarães dos ; Rossi, Giordano Novak; Hallak, Jaime Eduardo Cecilio ; Öngür, Dost; Dursun, Serdar M.
Source: Current Neuropharmacology. Unidade: FMRP
Subjects: ALUCINOGÊNICOS, ANTIDEPRESSIVOS, DEPRESSÃO, ANSIEDADE, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, EDITORIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach. Current Neuropharmacology. Sharjah: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/1570159X20666220425133824. Acesso em: 14 jun. 2024. , 2023
APA
Santos, R. G. dos, Rossi, G. N., Hallak, J. E. C., Öngür, D., & Dursun, S. M. (2023). Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach. Current Neuropharmacology. Sharjah: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.2174/1570159X20666220425133824
NLM
Santos RG dos, Rossi GN, Hallak JEC, Öngür D, Dursun SM. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach [Internet]. Current Neuropharmacology. 2023 ; 21( 1): 10-12.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1570159X20666220425133824
Vancouver
Santos RG dos, Rossi GN, Hallak JEC, Öngür D, Dursun SM. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach [Internet]. Current Neuropharmacology. 2023 ; 21( 1): 10-12.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1570159X20666220425133824
Artigo de periodico
The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol (2023)
Hartmann, Alice; Vila-Verde, Carla ; Guimarães, Francisco Silveira ; Wegener, Sâmia Regiane Lourenço Joca ; Lisboa, Sabrina Francesca de Souza
Source: Current Neuropharmacology. Unidades: FMRP, FCFRP, IRI
Subjects: CANABINOIDES, INFLAMAÇÃO, TECIDO NERVOSO, DEGENERAÇÃO NEURAL, DOENÇAS DO SISTEMA NERVOSO, TRANSTORNOS PSICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HARTMANN, Alice et al. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol. Current Neuropharmacology, v. 21, n. 2, p. 284-308, 2023Tradução . . Disponível em: https://doi.org/10.2174/1570159X20666220411101217. Acesso em: 14 jun. 2024.
APA
Hartmann, A., Vila-Verde, C., Guimarães, F. S., Wegener, S. R. L. J., & Lisboa, S. F. de S. (2023). The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol. Current Neuropharmacology, 21( 2), 284-308. doi:10.2174/1570159X20666220411101217
NLM
Hartmann A, Vila-Verde C, Guimarães FS, Wegener SRLJ, Lisboa SF de S. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol [Internet]. Current Neuropharmacology. 2023 ; 21( 2): 284-308.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1570159X20666220411101217
Vancouver
Hartmann A, Vila-Verde C, Guimarães FS, Wegener SRLJ, Lisboa SF de S. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol [Internet]. Current Neuropharmacology. 2023 ; 21( 2): 284-308.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1570159X20666220411101217

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration